Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Quotient Clinical at AAPS 2013

Published: Friday, November 08, 2013
Last Updated: Friday, November 08, 2013
Bookmark and Share
AAPS annual meeting and exposition to be held in San Antonio, Texas, from the 10th to the 14th of November.

Quotient Clinical will be showcasing the benefits of its unique, integrated approach to formulation development, real-time manufacturing and clinical testing on booth 2800 at this year’s American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition.

Held in San Antonio, Texas, from the 10th to the 14th of November, this meeting will provide delegates with the opportunity to see some of the latest developments in the pharmaceutical sector, including a variety of projects which have benefitted from the reduced costs and faster time-to-market offered by Quotient Clinical’s innovative development platform.

Quotient Clinical will be supporting several other activities and events at the meeting, including a RapidFACT™ user group meeting and six poster presentations.

The RapidFACT user meeting will aim to build on last year’s highly successful event, and will include a number of customer presentations, as well as an open forum to discuss various aspects of the RapidFACT process.

On the final day of the conference, Dr Alyson Connor, Director of Exploratory Clinical Pharmacology at Quotient Clinical, will be participating in a symposium featuring a number of prominent speakers from academia and industry entitled Understanding in vivo dissolution: can imaging tools provide the missing link?

Alyson will be discussing the practicalities of tracking oral dosage form performance using scintigraphic imaging, and participating in a panel discussion on the use of imaging tools in pharmaceutical research.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos